Urogen Pharma (URGN)
(Delayed Data from NSDQ)
$14.15 USD
+0.33 (2.39%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $14.16 +0.01 (0.07%) 7:58 PM ET
4-Sell of 5 4
F Value B Growth D Momentum D VGM
Earnings News For URGN
-
Urogen Pharma (URGN) Reports Q4 Loss, Tops Revenue Estimates
-
UroGen Pharma Reports Third Quarter 2023 Financial Results
-
Urogen Pharma (URGN) Reports Q2 Loss, Tops Revenue Estimates
-
UroGen Pharma Reports Record JELMYTO Quarterly Sales and Recent Corporate Developments
-
Urogen Pharma (URGN) Reports Q1 Loss, Tops Revenue Estimates
-
UroGen Pharma Meets Revenue Goal, Reports First Quarter 2023 Financial Results and Recent Corporate Developments
-
Earnings Preview: Urogen Pharma (URGN) Q1 Earnings Expected to Decline
-
Urogen Pharma (URGN) Reports Q4 Loss, Lags Revenue Estimates
-
UroGen Pharma Reports Highest Revenue Quarter and Significant Full Year 2022 Growth and Recent Corporate Developments
-
Urogen Pharma (URGN) Reports Q3 Loss, Lags Revenue Estimates
-
UroGen Pharma Reports Third Quarter 2022 Financial Results and Recent Corporate Developments
-
Urogen Pharma (URGN) Reports Q2 Loss, Lags Revenue Estimates
-
Urogen Pharma (URGN) Reports Q1 Loss, Misses Revenue Estimates
-
Urogen Pharma (URGN) Reports Q4 Loss, Tops Revenue Estimates
-
Urogen Pharma (URGN) Reports Q3 Loss, Misses Revenue Estimates
-
Urogen Pharma (URGN) May Report Negative Earnings: Know the Trend Ahead of Q3 Release
-
UROGEN PHARMA (URGN) Reports Q2 Loss, Tops Revenue Estimates
-
UROGEN PHARMA (URGN) Reports Q1 Loss, Misses Revenue Estimates
-
UROGEN PHARMA (URGN) Reports Q4 Loss, Tops Revenue Estimates